Stock listing
BIVI Stock Price, News, Filings & Events — Biovie Inc.
Selected listing: BIVI · NASDAQ · USD · US
This page tracks Biovie Inc.'s BIVI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIVI:NASDAQ. BIVI:NASDAQ is the stock-level entry point for investors researching Biovie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biovie Inc. (ticker: BIVI) is a public company operating in the American market with a market capitalization of approximately $17.12 million. The company focuses on developing innovative solutions in its sector. Investors can find relevant information about Biovie Inc. on its dedicated public company page.

- Ticker
- BIVI:NASDAQ
- Asset type
- Stock
- Market cap
- $10.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Biovie Inc. BIVI:NASDAQ stock context
This page tracks Biovie Inc.'s BIVI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIVI:NASDAQ. BIVI:NASDAQ is the stock-level entry point for investors researching Biovie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biovie Inc. (ticker: BIVI) is a public company operating in the American market with a market capitalization of approximately $17.12 million. The company focuses on developing innovative solutions in its sector. Investors can find relevant information about Biovie Inc. on its dedicated public company page.
Latest news from Biovie Inc.
BioVie Announces Update to Parkinson's Phase 3 Development Program
September 9, 2026
BioVie Announces Update to Parkinson’s Phase 3 Development Program
September 8, 2026
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated wi...
August 31, 2026
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
August 6, 2026
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
May 27, 2026
Research Biovie Inc.
Biovie Inc. investor report
Review AI stock analysis and investor report context for BIVI:NASDAQ.
Biovie Inc. company profile
View the public company page for Biovie Inc. on 6ix.
Biovie Inc. news
Read company news and market updates connected to Biovie Inc..
Biovie Inc. investor events
Find investor webinars, events, and replay context for Biovie Inc..